# Self Abrading Rapidly Applied Electrode Validation

> **NCT02200523** · NA · COMPLETED · sponsor: **Cleveland Medical Devices Inc** · enrollment: 40 (actual)

## Conditions studied

- ELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)

## Interventions

- **DEVICE:** SARA electrode
- **DEVICE:** Gold cup

## Key facts

- **NCT ID:** NCT02200523
- **Lead sponsor:** Cleveland Medical Devices Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200523, "Self Abrading Rapidly Applied Electrode Validation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02200523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*